Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma

Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma

Abstract Immunomodulatory agent lenalidomide is effective in treating follicular lymphoma (FL). We conducted the first trial of immunotherapy rituximab plus lenalidomide in newly diagnosed FL in China (NCT03715309). One-hundred and fifteen patients were enrolled and treated with rituximab 375 mg/m2...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhong Zheng, Jian-Biao Wang, Rui Sun, Nan Wang, Xiang-Qin Weng, Tian-Yuan Xu, Di Fu, Yan Feng, Peng-Peng Xu, Shu Cheng, Li Wang, Yan Zhao, Bin Qu, Chuan-Xin Huang, Wei-Li Zhao
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-01-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-024-02105-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Connexin 43 Communication Channels in Follicular Dendritic Cell Development and in Follicular Lymphomas
by: Hajnalka Rajnai, et al.
Published: (2015-01-01)

Disrupting EDEM3‐induced M2‐like macrophage trafficking by glucose restriction overcomes resistance to PD‐1/PD‐L1 blockade
by: Shaoyong Peng, et al.
Published: (2025-01-01)

Angioimmunoblastic T-Cell Lymphoma: A Questionable Association with Follicular Dendritic Cell Sarcoma
by: Daniel Benharroch, et al.
Published: (2017-01-01)

Modelling and analysis of a delayed viral infection model with follicular dendritic cell
by: Yan Geng, et al.
Published: (2024-08-01)

A humanized anti-MSLN×4-1BB bispecific antibody exhibits potent antitumour activity through 4-1BB signaling activation and fc function without systemic toxicity
by: Da-yan Zhang, et al.
Published: (2025-01-01)

Association between Virulence Factors and TRAF1/4-1BB/Bcl-xL Expression in Gastric Mucosa Infected with Helicobacter pylori
by: Fen Wang, et al.
Published: (2015-01-01)

Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin’s Lymphomas
by: Marco Gunnellini, et al.
Published: (2012-01-01)

Bibliometric analysis of the research landscape of PD-1/PD-L1 inhibitors in the treatment of bowel cancer
by: Qingwei Luo, et al.
Published: (2025-02-01)

Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility
by: Chenyue Qian, et al.
Published: (2018-01-01)

CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01)

Pancreatic Inflammatory Pseudotumor-Like Follicular Dendritic Cell Tumor
by: Madison Mograbi, et al.
Published: (2019-01-01)

Paraneoplastic Pemphigus Associated with Follicular Dendritic Cell Tumor in the Mediastinum
by: Aparna Mullangath Prakasan, et al.
Published: (2016-01-01)

Relationship between the ultrasound features of different molecular subtypes of breast cancer and positive PD-1/PD-L1 expression
by: Ruiqian Yan, et al.
Published: (2025-02-01)

Blockade of 4-1BB and 4-1BBL Interaction Reduces Obesity-Induced Skeletal Muscle Inflammation
by: Ngoc Hoan Le, et al.
Published: (2013-01-01)

Follicular Lymphoma In Situ Presenting as Dermatopathic Lymphadenopathy
by: Orah Nnamdi Obumneme, et al.
Published: (2013-01-01)

PMAIP1 regulates the progression of follicular thyroid carcinoma through the Wnt3/FOSL1 pathway
by: Haobo Wang, et al.
Published: (2025-01-01)

The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma
by: R. Palmieri, et al.
Published: (2019-01-01)

Clinical Significance of Negative Costimulatory Molecule PD-1/PD-L1 on Peripheral Blood Regulatory T Cell Levels among Patients with Pulmonary Tuberculosis
by: Chenchen Yang, et al.
Published: (2022-01-01)

Impact of positive CD4 cells on event‐free survival in follicular lymphoma patients
by: Cong Li, et al.
Published: (2024-09-01)

Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
by: Scott F. Huntington, et al.
Published: (2022-10-01)

Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1
by: Suli Wang, et al.
Published: (2024-11-01)

Clinicopathologic profile of intra-abdominal follicular dendritic cell sarcoma: A study of three cases with a literature review
by: Jianhong Yan, et al.
Published: (2023-01-01)

Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
by: Yanan Zhao, et al.
Published: (2024-08-01)

Immune-related adverse events with PD-1/PD-L1 inhibitors: insights from a real-world cohort of 2523 patients
by: Ting Yan, et al.
Published: (2025-01-01)

Effects of Clinicopathological Characteristics on the Survival of Patients Treated with PD-1/PD-L1 Inhibitor Monotherapy or Combination Therapy for Advanced Cancer: A Systemic Review and Meta-Analysis
by: Yuhan Wei, et al.
Published: (2020-01-01)

Successful Control of Acute Myelofibrosis with Lenalidomide
by: G. Vassilopoulos, et al.
Published: (2010-01-01)

Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
by: Nathan H. Fowler, et al.
Published: (2020-09-01)

Increased PD-1 expression in livers associated with PD-1-antibody-induced hepatotoxicity
by: Miro Saarela, et al.
Published: (2025-01-01)

WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis
by: Weiliang Jiang, et al.
Published: (2025-02-01)

Deep immunophenotypic dissection and clinical impact of T cells in the follicular lymphoma microenvironment
by: Sary El Daker, et al.
Published: (2025-02-01)

Plasmablastic transformation of a double hit follicular lymphoma: An emerging entity
by: Shanaz Khodaiji, et al.
Published: (2024-04-01)

Concurrent Diagnosis of Chronic Myeloid Leukemia and Follicular Lymphoma: An Unreported Presentation
by: Amy G. Starr, et al.
Published: (2018-01-01)

Characterization of Follicular Lymphoma in the Small Intestine Using Double-Balloon Endoscopy
by: Manzurul Chowdhury, et al.
Published: (2009-01-01)

The age-adjusted international prognostic index 2 (A-FLIPI2) for elderly patients with follicular lymphoma
by: Jiesong Wang, et al.
Published: (2025-02-01)

Bleeding Follicular Conjunctivitis due to Influenza H1N1 Virus
by: Maria Jesus Lopez-Prats, et al.
Published: (2010-01-01)

Baseline [18F]FDG PET/CT radiomics for predicting interim efficacy in follicular lymphoma treated with first-line R-CHOP
by: Zeying Wen, et al.
Published: (2025-01-01)

Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer
by: Rui Xu, et al.
Published: (2025-01-01)

4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
by: Ignacio Melero, et al.
Published: (2025-02-01)

Human Leukocyte Antigen Class I and II Alleles and Overall Survival in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
by: Yani Lu, et al.
Published: (2011-01-01)

Knockout IL4I1 affects macrophages to improve poor efficacy of CD19 CAR-T combined with PD-1 inhibitor in relapsed/refractory diffuse large B-cell lymphoma
by: Rui Zhang, et al.
Published: (2025-01-01)